Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function
Completed · Phase 1
Conditions studied: Renal Impairment, Healthy Participants
In brief
The primary objective of this study is to assess the pharmacokinetics (PK) of linzagolix in subjects with varying degrees of impaired renal function compared to matched control subjects with normal renal function
Key facts
- Study ID
- NCT03961932
- Run by
- ObsEva SA
- People needed
- 33
- Starts
- 2019-05-15
- Expected to finish
- 2020-01-31
- Last updated by the study team
- 2020-03-05
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
Where it is running
- Clinical Site — Orlando, Florida, United States
- Clinical Site — Saint Paul, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.